TXNDC5 is a novel therapeutic target of atrial fibrosis and fibrillation
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
National Taiwan University, Taipei (Taiwan)
12 More presentations in this session
Doctor S. Korste (Essen, DE)
Professor V. Golovko (Syktyvkar, RU)
Associate Professor M. Ohno (Otsu, JP)
Mr B. Linz (Copenhagen, DK)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
You may be interested in
Congress Session
Congress Presentation
Congress Session
